Screening for cervical cancer: When theory meets reality

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Nygård, Mari ^a  

^a Fr Nansens vei 19 ^*  (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; WART VIRUS VACCINE; ACETIC ACID; COLORING AGENT; DIAGNOSTIC AGENT;

CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER PREVENTION; CANCER REGISTRY; CANCER SCREENING; CLINICAL LABORATORY; COST EFFECTIVENESS ANALYSIS; DNA DETERMINATION; DOCTOR PATIENT RELATION; FOLLOW UP; HEALTH CARE FACILITY; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; MATHEMATICAL MODEL; MEDICAL AUDIT; MEDICAL DECISION MAKING; MORBIDITY; NOTE; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PATIENT EDUCATION; PATIENT MONITORING; PROFESSIONAL STANDARD; RESOURCE ALLOCATION; UTERINE CERVIX CANCER; WART VIRUS; CANCER PATIENT; DIAGNOSTIC TEST; LABORATORY TEST; NONHUMAN; PREVALENCE; PROGRAM EFFECTIVENESS; DNA PROBE; EARLY DIAGNOSIS; FEMALE; HEALTH CARE COST; HIGH THROUGHPUT SCREENING; MASS SCREENING; METHODOLOGY; PHYSICAL EXAMINATION; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR;

ACETIC ACID; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLORING AGENTS; DNA PROBES, HPV; DNA, VIRAL; EARLY DETECTION OF CANCER; FEMALE; HEALTH CARE COSTS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MASS SCREENING; PAPILLOMAVIRUS INFECTIONS; PHYSICAL EXAMINATION; UTERINE CERVICAL NEOPLASMS;

EID: 79958297001     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-240     Document Type: Note

References (10)

1. Cancer in Norway 2006. Cancer Incidence, mortality, survival and prevalence in Norway. Cancer in Norway 2007, Oslo: Cancer Registry of Norway.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127(12):2893-2917. 10.1002/ijc.25516, 21351269.
3. Dasbach EJ, Elbasha EH, Insinga RP. Mathematical models for predicting the epidemiologic and economic impact of vaccination against human papillomavirus infection and disease. Epidemiol Rev 2006, 28:88-100. 10.1093/epirev/mxj006, 16740585.
4. Bray F, Loos AH, McCarron P, Weiderpass E, Arbyn M, Moller H, Hakama M, Parkin DM. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev 2005, 14(3):677-686. 10.1158/1055-9965.EPI-04-0569, 15767349.
5. Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint A, Kotlum JE, Olafsdottir E, Pukkala E, Storm HH. NORDCAN--a Nordic tool for cancer information, planning, quality control and research. Acta Oncol 2010, 49(5):725-736. 10.3109/02841861003782017, 20491528.
6. IARC Cervix Cancer Screening. IARC Handbooks of Cancer Prevention 2005, 10. Lyon: IARC Press, IARC WgoteCPS, IARC.
7. Hansen BT, Hukkelberg SS, Haldorsen T, Eriksen T, Skare GB, Nygard M. Factors associated with non-attendance, opportunistic attendance and reminded attendance to cervical screening in an organized screening program: a cross-sectional study of 12,058 Norwegian women. BMC Public Health 2011, 11(1):264. 10.1186/1471-2458-11-264, 3111379, 21521515.
8. Nygard JF, Nygard M, Skare GB, Thoresen SO. Pap smear screening in women under 30 in the Norwegian Coordinated Cervical Cancer Screening Program, with a comparison of immediate biopsy vs Pap smear triage of moderate dysplasia. Acta Cytol 2006, 50(3):295-302. 10.1159/000325957, 16780024.
9. Leinonen M, Nieminen P, Kotaniemi-Talonen L, Malila N, Tarkkanen J, Laurila P, Anttila A. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. J Natl Cancer Inst 2009, 101(23):1612-1623. 10.1093/jnci/djp367, 19903804.
10. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla P, Del A, Ghiringhello B, Girlando S, Gillio-Tos A, De Marco L, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010, 11(3):249-257. 10.1016/S1470-2045(09)70360-2, 20089449.